196
Views
3
CrossRef citations to date
0
Altmetric
Original research

Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients

, ORCID Icon, &
Pages 511-518 | Received 08 Sep 2020, Accepted 02 Dec 2020, Published online: 22 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ghader Mohammadnezhad, Melika Sattarpour & Najmeh Moradi. (2022) Budget impact analysis of breast cancer medications: a systematic review. Journal of Pharmaceutical Policy and Practice 15:1.
Read now

Articles from other publishers (1)

Yue Ma, Yuxin Li, Aixia Ma & Hongchao Li. (2021) Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study. Frontiers in Public Health 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.